In-vitro and in-vivo evaluation of HCV polymerase inhibitors as potential drug candidates for treatment of chronic hepatitis C infection.

被引：0
|
作者：
Dagan, S
Ilan, E
Aviel, S
Nussbaum, O
Arazi, E
Ben-Moshe, O
Slama, D
Tzionas, I
Shoshany, Y
Lee, SW
Han, JJ
Park, SJ
Lee, GH
Park, EY
Shin, JC
Suh, JW
Ji, M
Kim, JW
机构：
[1] XTL Biopharmaceut Ltd, Rehovot, Israel
[2] B&C Biopharm, Kyungki, South Korea
[3] Myong Ji Univ, Yongin, Gyunggido, South Korea
来源：
HEPATOLOGY | 2003年 / 38卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
135
引用
收藏
页码：221A / 221A
页数：1
相关论文
共 50 条
  • [1] In-vitro and in-vivo evaluation of HCV polymerase inhibitors as potential drug candidates for treatment of chronic hepatitis C infection
    Dagan, S
    Ilan, E
    Aviel, S
    Nussbaum, O
    Arazi, E
    Ben-Moshe, O
    Slama, D
    Tzionas, I
    Shoshany, Y
    Lee, SW
    Han, JJ
    Park, SJ
    Lee, GH
    Park, EY
    Shin, JC
    Suh, JW
    Kim, JW
    JOURNAL OF HEPATOLOGY, 2004, 40 : 23 - 23
  • [2] In vitro and in vivo evaluation of HCV polymerase inhibitors as potential drug candidates for treatment of chronic hepatitis C infection
    Ilan, E
    Zauberman, A
    Aviel, S
    Nussbaum, O
    Arazi, E
    Ben-Moshe, O
    Slama, D
    Tzionas, I
    Shoshany, Y
    Lee, SW
    Han, JJ
    Park, SJ
    Lee, GH
    Park, EY
    Shin, JC
    Suh, JW
    Kim, JW
    Dagan, S
    ANTIVIRAL RESEARCH, 2004, 62 (02) : A83 - A83
  • [3] Evaluation of HFE mutations in patients with chronic hepatitis C virus (HCV) infection.
    Halangk, J
    Witt, H
    Puhl, G
    Gäbelein, G
    Müller, T
    Landt, F
    Neuhaus, P
    Wiedenmann, B
    Luck, W
    Berg, T
    HEPATOLOGY, 2004, 40 (04) : 683A - 683A
  • [4] Risk factors for the progression of chronic hepatitis C (HCV) infection.
    Rai, R
    Gruskin, L
    Nelson, K
    Vlahov, D
    Astemborski, J
    Thomas, D
    GASTROENTEROLOGY, 1997, 112 (04) : A1363 - A1363
  • [5] IN-VITRO AND IN-VIVO EVALUATION OF POTENTIAL ALUMINUM CHELATORS
    GRAFF, L
    MULLER, G
    BURNEL, D
    VETERINARY AND HUMAN TOXICOLOGY, 1995, 37 (05) : 455 - 461
  • [6] IN-VITRO AND IN-VIVO EVALUATION OF PEPTIDE ISOSTERE THROMBIN INHIBITORS
    DEADMAN, J
    SCULLY, MF
    CHENG, I
    CLAESON, G
    PATEL, G
    ELGENDY, S
    KAKKAR, VV
    THROMBOSIS AND HAEMOSTASIS, 1993, 69 (06) : 669 - 669
  • [7] Neurocognitive impairement in patients with chronic hepatitis C viral (HCV) infection.
    Darvesh, S
    Hirsch, G
    Fisk, J
    Peltekian, KM
    HEPATOLOGY, 2001, 34 (04) : 569A - 569A
  • [8] Leflunomide: A potential treatment for rheumatoid arthritis and chronic hepatitis C virus infection.
    Medina, FG
    Ortega, I
    Dehesa, M
    Carranza, I
    Fraga, A
    Moreno, J
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S565 - S566
  • [9] Cryoglobulinemic and noncryoglobulinemic neuropathy in chronic hepatitis C virus (HCV) infection.
    Wilson, L
    Reichler, B
    Gorevic, PD
    ARTHRITIS AND RHEUMATISM, 2000, 43 (09): : S192 - S192
  • [10] INTERFERON SYSTEM IS ACTIVATED IN-VIVO AND CAN BE STIMULATED IN-VITRO IN CHRONIC HEPATITIS-C
    CHOUSTERMAN, S
    ZYLBERBERG, H
    HAGEGE, H
    GAGNEPAIN, F
    THANG, MN
    CHOUSTERMAN, M
    GASTROENTEROLOGY, 1994, 106 (04) : A876 - A876
12345